These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35533257)

  • 1. The Impact of COVID-19 Pandemic on Screening Programs for Cervical Cancer Prevention Across Europe.
    Carcopino X; Cruickshank M; Leeson S; Redman C; Nieminen P
    J Low Genit Tract Dis; 2022 Jul; 26(3):219-222. PubMed ID: 35533257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National guidelines for management of cervical squamous intraepithelial lesion: A survey of European Federation for colposcopy members.
    Grigore M; Cruickshank ME; Nieminen P; Tjalma W; Moss E; Redman C
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():46-50. PubMed ID: 33166797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic.
    Ciavattini A; Delli Carpini G; Giannella L; Arbyn M; Kyrgiou M; Joura EA; Sehouli J; Carcopino X; Redman CW; Nieminen P; Cruickshank M; Gultekin M
    Int J Gynecol Cancer; 2020 Aug; 30(8):1097-1100. PubMed ID: 32487685
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical cancer screening in Poland in current SARS-CoV-2 pandemic: Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology - a summary January 2021.
    Jach R; Mazurec M; Trzeszcz M; Zimmer M; Kedzia W; Wolski H
    Ginekol Pol; 2021; 92(2):165-173. PubMed ID: 33751524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
    El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
    Elife; 2023 Jun; 12():. PubMed ID: 37377399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment.
    Fuzzell L; Brownstein NC; Fontenot HB; Lake PW; Michel A; Whitmer A; Rossi SL; McIntyre M; Vadaparampil ST; Perkins RB
    Elife; 2023 Sep; 12():. PubMed ID: 37656169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of the reported data of national rural cervical cancer screening project from 2012 to 2013, China].
    Luo XM; Song L; Wu JL; Liu Y; Di JL; Song B; Zheng RM; Ma L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):346-50. PubMed ID: 27029367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of colposcopy quality indicators-A survey among members of the European Federation for Colposcopy.
    Randrup TH; Leeson S; Ciavattini A; Eldib A; Grigore M; van Haaften-de Jong AM; Jariene K; Kesic V; Koiss R; Kotaniemi-Talonen L; Quaas J; Raud T; Zodzika J; Hammer A
    Acta Obstet Gynecol Scand; 2024 Sep; 103(9):1745-1752. PubMed ID: 38922851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
    Meggetto O; Jembere N; Gao J; Walker MJ; Rey M; Rabeneck L; Murphy KJ; Kupets R;
    BJOG; 2021 Aug; 128(9):1503-1510. PubMed ID: 33982870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European consensus statement on "HPV Vaccination and Colposcopy".
    Shafi MI; Petry U; Bosch XF; Gissman L; Kocken M; Helmerhorst TJ; Stanley M; Nazeer S; European Federation for Colposcopy
    J Low Genit Tract Dis; 2011 Oct; 15(4):309-15. PubMed ID: 21959574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future role for colposcopy in Europe.
    Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
    J Low Genit Tract Dis; 2014 Jan; 18(1):70-8. PubMed ID: 23774077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Welsh cervical screening programme learning as a consequence of the coronavirus pandemic.
    Leeson S; Evered A; Powell G; Lilly K; Singh N; Hillier S; Dunk L
    Cytopathology; 2022 May; 33(3):350-356. PubMed ID: 34935223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening in Europe: Quality assurance and organisation of programmes.
    Elfström KM; Arnheim-Dahlström L; von Karsa L; Dillner J
    Eur J Cancer; 2015 May; 51(8):950-68. PubMed ID: 25817010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
    JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia.
    Al-Mandeel HM; Sagr E; Sait K; Latifah HM; Al-Obaid A; Al-Badawi IA; Alkushi AO; Salem H; Massoudi NS; Schunemann H; Mustafa RA; Brignardello-Petersen R
    Ann Saudi Med; 2016; 36(5):313-320. PubMed ID: 27710981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary HPV screening for cervical cancer: Results after two screening rounds in a regional screening program in Finland.
    Veijalainen O; Kares S; Kotaniemi-Talonen L; Kujala P; Vuento R; Luukkaala T; Kholová I; Mäenpää J
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):403-409. PubMed ID: 33037625
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.